Despite an arsenal of drugs, many Americans are still unaware of their infections until it’s too late. A Biden initiative languishes without Congressional approval.
Category: Drugs (Pharmaceuticals)
-
FDA Approves Antibiotic to Treat Urinary Infections
Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and older.
-
How Ozempic Is Transforming a Small Danish Town
In Kalundborg, population under 17,000, Novo Nordisk is making huge investments to increase production of its popular diabetes and weight-loss drugs, Ozempic and Wegovy.
-
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy
Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
-
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
-
Global Stockpile of Cholera Vaccine Is Gone as Outbreaks Spread
One company is going to great lengths to build it up, but it will be years before it returns to the minimum level.
-
A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says
Results of a large clinical trial found the treatment did not work any better than a placebo.
-
The Psychedelic Evangelist
A Johns Hopkins scientist was known for rigorous studies of psychedelics. Was he a true believer?
-
With Cyberattack Fix Weeks Away, Health Providers Slam United
Hospitals, doctors and clinics expressed frustration that they will have to wait even longer for reimbursements after hackers paralyzed the largest U.S. billing clearinghouse.
-
A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market
Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.
-
F.D.A. Delays Action on Closely Watched Alzheimer’s Drug
Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.
-
Cyberattack Wreaks Havoc on Health Care Billing
The hack shut down the nation’s biggest health care payment system, causing financial chaos affecting a broad spectrum ranging from large hospitals to single-doctor practices.